LCA168 FOR GLIOBLASTOMA?

Glioblastoma is a aggressive brain malignancy known for its fast growth and insensitivity to typical treatments. Research are constantly underway to identify new management strategies, and recently, a unique biomarker named LCA168 has emerged as a potential avenue for GBM treatment. LCA168 is a protein that is abundantly produced in GBM cells comp